1. Understanding how RNA binding proteins can control cellular fate.
  2. Targeting MUSASHI-2 RNA binding protein as a new therapeutic target in myeloid leukemia.
  3. Understanding the role for RNA methylation function in normal and malignant blood cells.
Session date: 
05/20/2019 - 12:00pm to 1:00pm CDT
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael Kharas, PhD